Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

BACKGROUND: Primary sclerosing cholangitis (PSC) confers a high risk of cholangiocarcinoma (CC) development. Since patients at risk of CC may be selected for early liver transplantation, it is a challenge to identify any predisposing factors. We compared the presentation and natural history of a lar...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Boberg, K, Bergquist, A, Mitchell, S, Pares, A, Rosina, F, Broomé, U, Chapman, R, Fausa, O, Egeland, T, Rocca, G, Schrumpf, E
التنسيق:	Journal article
اللغة:	English
منشور في:	2002

مواد مشابهة

Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patients.
حسب: Boberg, K, وآخرون
منشور في: (2001)

Natural history of primary sclerosing cholangitis. A longterm follow-up study of 394 European primary sclerosing cholangitis patients
حسب: Boberg, K, وآخرون
منشور في: (2000)

New time dependent prognostic models for primary sclerosing cholangitis (PSC)
حسب: Rocca, G, وآخرون
منشور في: (2000)

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.
حسب: Boberg, K, وآخرون
منشور في: (2002)

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.
حسب: Boberg, K, وآخرون
منشور في: (2001)

Prognostic indicators of primary sclerosing cholangitis determined by a cox phase-specific time-dependent model.
حسب: Boberg, K, وآخرون
منشور في: (1998)

HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups.
حسب: Saarinen, S, وآخرون
منشور في: (1998)

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.
حسب: Spurkland, A, وآخرون
منشور في: (1999)

Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.
حسب: Björnsson, E, وآخرون
منشور في: (2002)

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
حسب: Bansi, D, وآخرون
منشور في: (1997)

Detection of antineutrophil cytoplasmic antibody in primary sclerosing cholangitis: Comparison of the alkaline phosphatase and immunofluorescent techniques.
حسب: Bansi, D, وآخرون
منشور في: (1996)

DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES
حسب: Bansi, D, وآخرون
منشور في: (1995)

Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review
حسب: Annika Bergquist, وآخرون
منشور في: (2024-02-01)

The natural history of small-duct primary sclerosing cholangitis
حسب: Bjornsson, E, وآخرون
منشور في: (2007)

The natural history of small-duct primary sclerosing cholangitis.
حسب: Björnsson, E, وآخرون
منشور في: (2008)

Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis.
حسب: Martins, E, وآخرون
منشور في: (1994)

Patients with small duct primary sclerosing cholangitis have favorable long term prognosis.
حسب: Bjornsson, E, وآخرون
منشور في: (2001)

Primary sclerosing cholangitis.
حسب: Mitchell, SA, وآخرون
منشور في: (2000)

Are dominant strictures in primary sclerosing cholangitis a risk factor for cholangiocarcinoma?
حسب: Chapman, R, وآخرون
منشور في: (2017)

HLA associations in small-duct compared with large-duct primary sclerosing cholangitis
حسب: Naess, S, وآخرون
منشور في: (2012)

Diagnosis and management of primary sclerosing cholangitis.
حسب: Chapman, R, وآخرون
منشور في: (2010)

The management of primary sclerosing cholangitis.
حسب: Mitchell, SA, وآخرون
منشور في: (1998)

Primary sclerosing cholangitis
حسب: Chapman, R
منشور في: (2007)

Primary sclerosing cholangitis.
حسب: Chapman, R
منشور في: (1985)

Primary sclerosing cholangitis.
حسب: Cullen, S, وآخرون
منشور في: (2003)

Primary sclerosing cholangitis.
حسب: Williamson, K, وآخرون
منشور في: (2014)

Primary sclerosing cholangitis.
حسب: Worthington, J, وآخرون
منشور في: (2006)

Primary sclerosing cholangitis
حسب: Chapman Roger, وآخرون
منشور في: (2006-10-01)

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
حسب: Mitchell, SA, وآخرون
منشور في: (2001)

Ulcerative colitis: sclerosing cholangitis today, cancer tomorrow?
حسب: Broomé, U, وآخرون
منشور في: (1997)

Review article: the management of primary sclerosing cholangitis.
حسب: Mitchell, SA, وآخرون
منشور في: (1997)

The management of primary sclerosing cholangitis.
حسب: Chapman, R
منشور في: (2003)

The immunology of primary sclerosing cholangitis.
حسب: Chapman, R
منشور في: (1990)

Primary sclerosing cholangitis - Foreword
حسب: Chapman, R
منشور في: (2006)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
حسب: Chapman, R
منشور في: (1993)

Etiopathogenesis of primary sclerosing cholangitis.
حسب: Chapman, R, وآخرون
منشور في: (2008)

Aetiopathogenesis of primary sclerosing cholangitis.
حسب: Cullen, S, وآخرون
منشور في: (2001)

Unusual Presentation of Primary Sclerosing Cholangitis
حسب: BC Pineau, وآخرون
منشور في: (1997-01-01)

Is the 308 polymorphism in the tumor necrosis factor (alpha) (TNF alpha) promoter region a marker of disease susceptibility in European patients with primary sclerosing cholangitis (PSC)?
حسب: Mitchell, SA, وآخرون
منشور في: (1998)

An update on primary sclerosing cholangitis.
حسب: Maggs, JR, وآخرون
منشور في: (2008)